Vivos Therapeutics/ US92859E2072 /
| 2024-06-03 6:40:54 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 2.08USD | - | 5 Turnover: 10.42 |
-Bid Size: - | -Ask Size: - | 2.09 | 2.08 |
GlobeNewswire
05-20
Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-E...
GlobeNewswire
05-14
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
05-14
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
04-09
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursem...
GlobeNewswire
03-28
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operatio...
GlobeNewswire
03-28
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conf...
GlobeNewswire
02-15
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Pro...
GlobeNewswire
02-06
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...
GlobeNewswire
01-08
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of...
GlobeNewswire
2023-12-11
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
GlobeNewswire
2023-11-29
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obs...
GlobeNewswire
2023-11-14
Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
GlobeNewswire
2023-11-09
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
GlobeNewswire
2023-10-31
Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasd...
GlobeNewswire
2023-10-05
Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Suppo...
GlobeNewswire
2023-10-04
Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Sp...
GlobeNewswire
2023-10-02
New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos ...
GlobeNewswire
2023-08-16
Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
GlobeNewswire
2023-08-16
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
GlobeNewswire
2022-03-08
Fast Company Selects Vivos Therapeutics for 2022 “World’s Most Innovative Companies” List
